1 November 2019 - Deborah Wilkes
Pharmavite has hired a chief marketing officer, RB and BioGaia have new chief financial officers, and the US Council for Responsible Nutrition (CRN) has a new vice president of government relations.
Pharmavite hires marketing chief
Pharmavite has hired Elanco Animal Health’s Rhonda Hoffman as chief marketing officer.
The US-based vitamins, minerals and supplements (VMS) specialist said Hoffman would lead all of its marketing efforts, including brand development, consumer insights, advertising and organisation development.
At Elanco Animal Health, Hoffman was responsible for a multi-billion dollar brand portfolio. She previously spent nearly a decade at Abbott where she worked on brands such as Similac, Pedialyte and PediaSure. Furthermore, she launched Vrios, a global innovation and marketing consultancy for health and wellness, VMS and beauty/personal care companies.
Pharmavite is a subsidiary of Japan's Otsuka Pharmaceutical Co.
Hennah retiring from RB
RB has announced that Adrian Hennah is retiring as chief financial officer and executive director after seven years in the post.
Hennah will be replaced by Jeff Carr who is chief financial officer and a member of the management board and executive committee at Netherlands-based retailer Ahold Delhaize.
RB said Carr would join the company on or before 9 April 2020. Hennah will step down from his current post when Carr starts but will remain with RB until his retirement date of 21 October 2020 to ensure a seamless transition.
Carr previously worked for RB in senior finance roles between 1994 and 2004. He has also worked for Associated British Foods, easyJet, Grand Metropolitan and Unilever.
BioGaia has new finance chief
BioGaia has recruited Alexander Kotsinas as chief financial officer with effect from 5 November 2019. He is currently finance director at Lowell.
Kotsinas will replace Margareta Hagman who is leaving the Swedish probiotics specialist after 23 years.
In the third quarter of 2019, BioGaia reported worldwide sales down by 4% to SEK167 million (USD17.4 million).
The company said the fall was due to “delivery delays from our supplier in Belgium and lower royalty revenues”. Isabelle Ducellier, BioGaia’s president and chief executive officer, said the decline in sales was “temporary” and the delays would not affect the company’s “long-term expectations and sales and marketing strategies”.
BioGaia’s Paediatrics business recorded sales down by 7% to SEK128 million, while sales by the Adult Health business were up by 8% to SEK38.8 million.
Operating profit was down by 25% to SEK49.5 million.
CRN has a new vice president
The US CRN has appointed Julia Gustafson as vice president of government relations.
Gustafson joins from the Corn Refiners Association (CRA) where she was counsel and director of legislative affairs. During her time at the CRA, she drafted and oversaw the development of dozens of laws, including bills that authorised federal programmes critical to the CRA and its members.
At the CRN – the US trade association for the dietary supplement and functional food industry – Gustafson will lead federal and state legislative and strategic policy initiatives. She will report to the CRN’s president and chief executive officer Steve Mister.